Molecular genetics of schizophrenia: A critical review

Journal of Psychiatry and Neuroscience

Volumn 28, Issue 6, 2003, Pages 415-429

  Berry, Neeraj ^a   Jobanputra, Vaidehi ^a   Pal, Hemraj ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Behavioral; Genetic predisposition to disease; Genetics; Linkage (genetics); Linkage disequilibrium; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; GLUTAMATE RECEPTOR; NEU DIFFERENTIATION FACTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

ALLELE; CHROMOSOME 1; CHROMOSOME 11; CHROMOSOME 13; CHROMOSOME 13Q; CHROMOSOME 15; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME 8P; CLINICAL TRIAL; EPIGENETICS; ETHNIC DIFFERENCE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOME; HUMAN; MATHEMATICAL COMPUTING; META ANALYSIS; METHODOLOGY; MOLECULAR GENETICS; NEUROTRANSMISSION; REVIEW; RISK; SCHIZOPHRENIA; SEX CHROMOSOME;

CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 6; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE DISEQUILIBRIUM; MOLECULAR BIOLOGY; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5; RECEPTORS, GABA; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, SEROTONIN; SCHIZOPHRENIA; TRINUCLEOTIDE REPEATS;

EID: 0347126342     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Kendler KS, McGuire M, Gruenberg AM, Walsh D. An epidemiological, clinical and family study of simple schizophrenia in County Roscommon, Ireland. Am J Psychiatry 1994; 151:27-34.
2. Tsuang MT, Gilbertson MW, Faraone SV. The genetics of schizophrenia. Current knowledge and future directions. Schizophr Res 1991;4:157-71.
3. Kendler KS. Overview: a current perspective on twin studies of schizophrenia. Am J Psychiatry 1983;140:1413-25.
4. Kety SS. Schizophrenic illness in the families of schizophrenic adoptees: findings from the Danish national sample. Schizophr Bull 1988;14:217-22.
5. Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, et al. Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 1988;336:164-7.
6. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995;11(3):241-7.
7. Bassett AS. Chromosome 5 and schizophrenia: implications for genetic linkage studies. Schizophr Bull 1989;15:393-402.
8. Paunio T, Ekelund J, Varilo T, Parker A, Hovatta I, Turunen JA, et al. Genome-wide scan in a nation wide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet 2001;10:3037-48.
9. Hovatta I, Lichtermann D, Juvonen, H, Suvissari J, Terwilliger JD, Ara Jarvi R, et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in population based sampled Finnish family set. Mol Psychiatry 1998;3:452-7.
10. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997;2:148-55.
11. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Ertl MA, et al. Evidence suggestive of a locus on chromosome 5q31 contributing to the susceptibility to schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997;2:156-60.
12. Gurling H, Kalsi G, Brynjolfsson J, Sigmundsson T, Sherrington R, Baljinder S, et al. Genome wide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q 32.2, 5q 33.2 and 8p 21-22 and provides support for linkage to schizophrenia, on chromosomes 11q 23.3-24 and 20q 12.1-11.23. Am J Hum Genet 2001;68:661-73.
13. Silverman JM, Greenberg DA, Altstiel LD, Davis KL, Siever IJ, Moks RC, et al. Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet 1996;67;162-71.
14. King N, Bassett AS, Honer WG, Masellis M, Kennedy JL. Absence of linkage for schizophrenia on short arm of chromosome 5 in multiplex Canadian families. Am J Med Genet 1997; 74;472-4.
15. Crowe RR, Vieland W. Report of the chromosome 5 workshop of the Sixth World Congress on Psychiatric Genetics. Am J Med Genet 1999;88:229-32.
16. Straub RE, Maclean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. A potential vulnerability locus for schizophrenia on chromosome 6p 24-22: evidence for genetic heterogeneity. Nat Genet 1995;11;287-93.
17. Schwab SG, Hallmayer J, Albus M, Borrmann M, Segman RH, Hanses C. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiatry 2000;5:638-49.
18. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D, et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multi point affected sib-pair linkage analysis. Nat Genet 1995;11:325-7.
19. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F, et al. An international two stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995; 11:321-4.
20. Bruzustowicz LM, Honer WG, Chow EW, Hogan J, Hodgkinson K, Bassett AS. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet 1997;61:1388-96.
21. Deng H, Liu X, Cai G, Terwedow H, Wang Z, Xu X. Linkage disequilibrium study of microsatellite markers on chromosome 6 and schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:6-9.
22. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter p22. Nat Genet 1995;10:41-6.
23. Martinez M, Goldin LR, Cao Q, Zhang J, Sander AR, Nancarrow DJ, et al. Follow up study on a susceptibility locus for schizophrenia on chromosome 6q. Am J Med Genet 1999;88:337-43
24. Lindholm E, Ekholm B, Shaw S, Jalonen P, Johansson G, Pettersson U, et al. A schizophrenia susceptibility locus at 6q 25 in one of the world's largest reported pedigrees. Am J Hum Genet 2001;69:96-105.
25. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchi A, et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 1997;43:1-8.
26. Gurling H, Kalsi G, Chen A, Green M, Butler R, Read T, et al. Schizophrenia susceptibility and chromosome 6p 24-22. Nat Genet 1995;11:234-5.
27. Mowry BJ, Nancarrow DJ, Lennon DP, Crow RR, Sandkuijl LA, Silverman JM, et al. Schizophrenia susceptibility and chromosome 6p24-22. Nat Genet 1995;11;233-4.
28. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, et al. A genome wide search for schizophrenia susceptibility genes. Am J Med Genet 1998;81:364-76.
29. Joo EJ, Cannon TD, Lee JH, Price CA. Possible association between schizophrenia and a CAG repeat polymorphism in the spinocerebellar ataxia type 1 (SCA1) gene on human chromosome 6p23. Psychiatr Genet 1999;9:7-11.
30. Pujana MA, Martorell L, Volpini V, Valero J, Labad A, Viella E, et al. Analysis of amino acid and nucleotide variants in spinocerebellar ataxia type 1 [SCAI] gene in schizophrenic patients. Hum Genet 1997;99:772-5.
31. Bell R, Collier DA, Kerwin RW, Gloger IS, Rice SQ, Roberts GW, et al. Systematic screening of the LDL-PLA2 gene for polymorphic variants and case control analysis in schizophrenia. Biochem Biophys Res Commun 1997;241:630-5
32. Sklar P, Schwab SG, Williams NM, Daly M, Maier W, Albus M, et al. Association analysis of NOTCH4 loci in schizophrenia using family and population based controls. Nat Genet 2001; 28:126-8.
33. Blackwood DH, Muir WJ, Stephenson A, Wentzel J, Clair DM, Robets DF, et al. Reduced expression of HLA-B35 in schizophrenia. Psychiatr Genet 1996;6:51-9.
34. Fan JB, Tang JX, Gu NF, Feng GY, Zou FG, Xing YL, et al. A family based and case-control association study of the NOTCH4 gene and schizophrenia. Mol Psychiatry 2002;7:100-3.
35. Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet 2002;359:426-30.
36. Myles-Worsley M, Coon H, McDowell J, Brenner C, Hoff M, Lind B, et al. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families. Am J Med Genet 1999;88:544-50.
37. Kunugi H, Vallada HP, Sham PC, Hoda F, Arrang MJ, Li T, et al. Catechol-O-methyl transferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 1997;7:97-101.
38. Parsian A, Suarez BK, Isenberg K, Hampe CL, Fisher L, Chakraverty S, et al. No evidence of schizophrenia susceptibility gene in the vicinity of IL2RB on chromosome 22. Am J Med Genet 1997;74:361-4.
39. Williams NM, Jones LA, Murphy KC, Cardno AG, Asherson P, Williams J, et al. No evidence for an allelic association between schizophrenia and markers D22 S278 and D22 S283. Am J Med Genet 1997;74:37-9.
40. Riley B, Mogudi-Carter M, Jenkins T, Williamson R. No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families. Am J Med Genet 1996;67:515-22.
41. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-22. Science 2000;288:678-82.
42. Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, Martin R, et al. Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 2001;10:1611-7.
43. Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AF, Gejman PV, et al. No major schizophrenia locus detected on chromosome 1q in a large multicentre sample. Science 2002;296: 739-41.
44. Freedman R, Leonard S, Gault J. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha-7-nicotinic acetylcholine receptor subunit gene [CHRNA 7]. Am J Med Genet 2001;105:20-2.
45. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Oliney A, et al. Further investigation of a chromosome 15 locus in schizophrenia: analysis of affected sibpairs from the NIMH Genetics Initiative. Am J Med Genet 1998;81:308-12.
46. Freedman R, Leonard S, Olincy A, Kaufmann CA, Malaspina D, Cloninger CR, et al. Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet 2001;105:794-800.
47. Gejman PV, Sanders AR, Cao Q, Zhang J. Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet 2001;105: 789-93.
48. Tsuang DW, Skol A, Faraone SV, Bingham S, Young KA, Prabhudesai S, et al. Genetic linkage of the CHRNA7 region on chromosome 15 to schizophrenia in a large Veterans Affairs cooperative study sample. Am J Med Genet 2001;105:662-8.
49. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, et al. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene [CHRNA7] locus and schizophrenia in Azorean families. Am J Med Genet 2001;105:669-74.
50. Liu CM, Hwu HG, Lin MW, Ou-Yang WC, Lee SF, Fann CS, et al. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet 2001;105:658-61.
51. Maziade M, Raymond V, Cliche D, Fournier JR, Caron C, Garneau Y, et al. Linkage results on 11q 21-22 in Eastern Quebec pedigrees densely affected by schizophrenia. Am J Med Genet 1995;60:522-8.
52. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Mowry BJ, et al. Genome scan of schizophrenia. Am J Psychiatry 1998;155:741-50.
53. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suraez B, et al. Genome scan of European-American Schizophrenic pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998;81:290-5.
54. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, et al. Further evidence for a susceptibility locus on chromosome 10p14-11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998;81:302-7.
55. Strab RE, MacLean CJ, Martin RB, Ma Y, Myakishe MV, Harris-Kerr C, et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998;81:296-301.
56. Bruzustowicz LM, Honer WG, Chow EWC, Little D, Hogan J, Bassett AS. Linkage of familial schizophrenia to chromosome 13q32. Am J Hum Genet 1999;65:1096-103.
57. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, et al. Evidence of a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High density Schizophrenia Families. Am J Psychiatry 1996;153:1534-40.
58. Blouin JC, Dombroski BA, Nath SK, Lasseter VK, Neufeld K, Pulver AE, et al. Schizophrenia susceptibility loci on chromosomes 13q 22 and 8p21. Nat Genet 1998;20:70-3.
59. Faraone SV, Skol AD, Tsuang DW, Bingham S, Young KA, Prabhudesai S, et al. Linkage of chromosome 13q32 to schizophrenia in a large veteran affairs cooperative study sample. Am J Med Genet 2002;114:598-604.
60. Lin MW, Curtis D, Williams N, Arranz M, Nanko S, Collier D, et al. Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q32. Psychiatr Genet 1995;5: 117-26.
61. Sturt E, Shur E. Sex concordance for schizophrenia in proband-relative pairs. Br J Psychiatry 1985;147:44-7.
62. Crow TJ. Sex chromosome and psychosis: the case for a pseudoautosomal locus. Br J Psychiatry 1998;153:675-83.
63. Delisi LE, Devoto M, Lofthouse R, Poulter M, Smith A, Shields G, et al. Search for linkage to schizophrenia on the X and Y chromosomes. Am J Med Genet 1994;54:113-21.
64. Kalsi G, Curtis D, Brynjolfsson J, Butler R, Sharma T, Murphy P, et al. Investigation by linkage analysis of the XY pseudoautosomal region in the genetic susceptibility to schizophrenia. Br J Psychiatry 1995;167:390-3.
65. Lichtermann D, Hovatta I, Terwilliger JD, Peltonen L, Lonnqvist J. Concordance for sex and the pseudoautosomal gene hypothesis revisited: no evidence of increased sex concordance in a nationwide Finnish sample of siblings with paternally derived schizophrenia. Am J Psychiatry 1998;155:1365-75.
66. Kalsi G, Gamble D, Curtis D, Butler R, Read T, Murphy P, et al. No evidence for linkage of schizophrenia to DXS7 at chromosome Xp 11. Psychiatr Genet 1999;9:197-9.
67. DeLisi LE, Shaw S, Sherington R, Nanthaa Kumar B, Sheilds G, Smith AB, et al. Failure to establish linkage on the X chromosome in 301 families with schizophrenia or schizoaffective disorder. Am J Med Genet 2000;96:335-41.
68. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW, et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 2002;159:803-12.
69. DeLisi LE, Mesen A, Rodriguez C, Bertheau A, LalPrade B, Llach M, et al. Genome-wide scan for linkage to schizophrenia in a Spanish origin cohort from Costa Rica. Am J Med Genet 2002;114:497-508.
70. Carver DI, Holocomb J, Mapua FM, Wilson R, Barnes B. Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigrees. Schizophr Res 2001;52:145-60.
71. Badner JA, Gershon ES. Meta-analysis of whole genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002;7(4):405-11
72. Williams NM, Rees MI, Holmans P, Norton N, Cardno A, Jones LA, et al. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet 1999;8:1729-39.
73. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, et al. NIMH Genetics Initiative Millennium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet 1998;81:282-9.
74. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R, et al. A genome wide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999;65:1114-24.
75. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Genome scans for schizophrenia genes: a detailed progress report in an Irish cohort. Am J Med Genet 1997;74:558.
76. Paunio T, Ekelund J, Hovatta I, Varilo T, Terwilliger JD, Meyer J, et al. Genome wide scan of an extended Finnish schizophrenia study sample. Am J Med Genet 2000;96:460.
77. Rice JP. The role of meta-analysis in linkage studies of complex traits. Am J Med Genet 1997;74:112-4.
78. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994:15:264-70.
79. Hartman DS, Civelli O. Molecular attributes of dopamine receptors: new potential for antipsychotic drug development. Ann Med 1996;28:211-9.
80. Arinami T, Itokawa M, Enguchi H, Tagaya H, Yano S, Shimizu H, et al. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994;343:703-4.
81. 2 receptor gene promoter and schizophrenia. Psychiatry Res 1998;81:117-23.
82. Kaneshima M, Higa T, Nakamoto H, Nagamine M. An association study between the Cys 311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population. Psychiatry Clin Neurosci 1997;51:379-81.
83. Tallerico T, Ulpian C, Liu IS. Dopamine D2 receptor promoter polymorphism: no association with schizophrenia. Psychiatry Res 1999;85:215-9.
84. Serretti A, Lilli R, Lorenzi C, Smeraldi E. Further evidence supporting the association between the dopamine receptor D2 Ser / Cys 311 variant and disorganized symptomatology of schizophrenia. Schizophr Res 2000;43:161-2.
85. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenia patients. Schizophr Res 2001; 49:203-12.
86. Crocq MA, Mant R, Asherson P, William J, Hode Y, Mayerova A, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992;29:858-60.
87. Mant R, Williams J, Asherson P, Parfitt E, Mcguaffin P, Owen MJ. Relationship between homozygosity at the dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1994;54:21-6.
88. Kennedy JL, Billett EA, Macciardi FM, Verga M, Parsons TJ, Meltzer HY, et al. Association study of dopamine D3 receptor gene and schizophrenia. Am J Med Genet 1995;60:558-62.
89. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998;3:458.
90. Sivagnanasundaram S, Morris AG, Gaitonde EJ, McKenna PJ, Mollon JD, Hunt DM. A cluster of single nucleotide polymorphisms in the 5′-leader of the human dopamine D3 receptor gene [DRD3] and its relationship to schizophrenia. Neurosci Lett 2000;279:13-6.
91. Johnson E, Lanfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatr Scand 1993;87:345-9.
92. Inada T, Sugita T, Dobashi I, Inagaki A, Kitao Y, Matsuda G, et al. Dopamine D3 receptor gene polymorphism and the psychiatric symptoms seen in first break schizophrenic patients. Psychiatr Genet 1995;5:113-6.
93. Hawi Z, McCabe U, Straub RE, O'Neill A, Kendler KS, Walsh D, et al. Examination of new and reported data of the DRD3/MSCI polymorphism: no support for the proposed association with schizophrenia. Mol Psychiatry 1998;3:150-5.
94. Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K, et al. European Multicentre Association study of schizophrenia : a study of the DRD2 and Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 1998;81(1):24-8.
95. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 1998;3(2):141-9.
96. Van Tol HH, Bunzow JR, Guan HC, Seeman P, Niznik HB, Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;350:610-4.
97. Maier W, Schwab S, Hallmayer J, Ertl MA, Minges J, Ackenhil M, et al. Absence of linkage between schizophrenia and the dopamine D4 receptor gene. Psychiatry Res 1994;53:77-86.
98. Shaikh S, Gill M, Owen M, Asherson P, McGuffin P, Nanko S, et al. Failure to find linkage between a functional polymorphism in the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1994;54:8-11.
99. Jonsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, et al. No association between a promoter dopamine D4 receptor gene variant and schizophrenia. Am J Med Genet 2001;105:525-8.
100. Serretti A, Lilli R, Di Bella D, Bertelli S, Nobile M, Nouelli E, et al. Dopamine receptor D4 gene is not associated with major psychosis. Am J Med Genet 1999;88:486-91.
101. Sobell JL, Lind TJ, Sigurdson DC, Somner SS, Zald DH, Snitz BE, et al. The D5 dopamine receptor gene in schizophrenia: identification of a nonsense change and multiple missense changes but lack of association with disease. Hum Mol Genet 1995;4:507-14.
102. Williams NM, Cardino AG, Murphy KC, Jones LA, Asherson P, McGuffin P, et al. Association between schizophrenia and a microsatellite polymorphism at the dopamine D5 receptor gene. Psychiatr Genet 1997;7:83-5.
103. Muir WJ, Thomson ML, McKeon P, Mynett-Johnson L, Whitton C, Evans KL, et al. Markers close to the dopamine D5 receptor gene [DRD5] show significant association with schizophrenia but not bipolar disorder. Am J Med Genet 2001; 105:152-8.
104. Li T, Yang L, Wiese C, Xu CT, Zeng Z, Giros B, et al. No association between alleles or genotypes at the dopamine transporter gene and schizophrenia. Psychiatry Res 1994;52:17-23.
105. Martinez D, Gelernter J, Ali-Dargham A, van Dyck CH, Kegeles L, Inmis RB, et al. The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology 2001;24:553-60.
106. Byerley W, Coon H, Hoff M, Holik J, Waldo M, Freedman R, et al. Human dopamine transporter gene not linked to schizophrenia in multigenerational pedigrees. Hum Hered 1993;43: 319-22.
107. Coon H, Byerley W, Holik J, Hoff M, Myles-Worsley M, Lannfelt L, et al. Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am J Hum Genet 1993;52:327-34.
108. 3 receptor gene not associated with symptomatology of major psychosis. Am J Med Genet 1999;88:476-80.
109. Moises HW, Gelernter J, Giuffra LA, Zarcone V, Wetterberg L, Civelli O, et al. No linkage between D2 dopamine receptor gene region and schizophrenia. Arch Gen Psychiatry 1991;48:643-7.
110. Su Y, Burke J, O'Neill FA, Murphy B, Nie L, Kipps B, et al. Exclusion of linkage between schizophrenia and D2 dopamine receptor gene region of chromosome 11 q in 112 Irish multiplex families. Arch Gen Psychiatry 1993;50:205-11.
111. Ohara K, Nagai M, Tani K, Tsukamoto T, Ohara K. Schizophrenia and the serotonin 2A receptor promoter polymorphism. Psychiatry Res 1999;85:221-4.
112. Gothert M, Propping P, Bonisch H, Bruss M, Nothen MM. Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role. Ann N Y Acad Sci 1998;861: 26-30.
113. He L, Li T, Melville C, Liu S, Fang GY, Collier D, et al. 102 T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations. Am J Med Genet 1999;88:95-8.
114. Chen CH, Lee YR, Wei FC, Koong FJ, Hure HG, Hsiao KJ. Lack of allelic association between 102 T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatr Genet 1997;7:35-8.
115. Serretti A, Lilli R, Lorenzi C, Lattuada E, Cusin C, Smeraldi E. Serotonin transporter gene [5HTTLPR] and major psychosis. Mol Psychiatry 2002;7:95-9.
116. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Brier A, Pickar D. A functional serotonin transporter [5-HTT] polymorphism is associated with psychosis in neuroleptic free schizophrenics. Mol Psychiatry 1998;3:328-32.
117. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res 1995;29:211-23.
118. Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am J Psychiatry 2001;158:1400-10.
119. Ohnuma T, Augood SJ, Emson PC, Arai H, Mckenna PJ. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the pre-frontal cortex from normal individuals and patients with schizophrenia. Brain Res Mol Brain Res 1998;56;207-17.
120. Riley BP, Tahil E, Rajagopalan S, Mogudi-Carter M, Jenkins T, Williamson R, et al. A linkage study of the N-methyl D aspartate receptor subunit gene loci and schizophrenia in Southern African Bantu Speaking families. Psychiatr Genet 1997;7:57-74.
121. Devson RS, Porteus DJ. Physical mapping of glutamate receptor gene in relation to a balanced translocation associated with schizophrenia in a large Scottish family. Psychiatr Genet 1997;7: 165-9.
122. Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y. Structure and polymorphism of the human metabotropic glutamate receptor type 2 gene [mGluR2]: analysis of association with schizophrenia. Mol Psychiatry 2001; 6:186-92.
123. Semple CA, Devson RS, Le Hellard S, Porteous DJ. Identification of genes from schizophrenia-linked translocation breakpoint region. Genomics 2001;73:123-6.
124. Papadimitriou G, Dikeos D, Daskalopoulou E, Kardima G, Avramopoulos D, Contis C, et al. Association between GABA-A receptor alpha 5 subunit gene locus and schizophrenia of a later age of onset. Neuropsychobiology 2001;43:141-4.
125. Coon H, Sobell J, Heston L, Sommer S, Hoff M, Holik J, et al. Search for mutations in the beta 1 GABAA receptor subunit gene in patients with schizophrenia. Am J Med Genet 1994;54:12-20.
126. Volk D, Austin M, Pierri J, Sampson A, Lewis D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 2001;158:256-65.
127. Shinkai T, Ohmori O, Suzuki T, Kojima H, Hori H, Terao T, et al. Polymorphisms of tryptophan hydroxylase case gene and the symptomatology of schizophrenia: an association study. Psychiatr Genet 2000;10:165-71.
128. Hong CJ, Tsai SJ, Wang YC. Association between tryptophan hydroxylase gene polymorphism [A218C] and schizophrenic disorders. Schizophr Res 2001;49:59-63.
129. Herken H, Erdal ME. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatr Genet 2001; 11:105-9.
130. Semwal P, Prasad S, Bhatia T, Deshpande SN, Wood J, Nimgaonkar VL, et al. Family based association studies of monoaminergic gene polymorphism among North Indians with schizophrenia. Mol Psychiatry 2001;6:220-4.
131. McGuffin P, Tandon K, Curisco A. Linkage and association studies of schizophrenia. Curr Psychiatry Rep 2003;5(2):121-7
132. Straub RE, Jiang Y, Maclean CJ, Ma Y, Webb BT, Myakishev MV, et al. Genetic variation in the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002;71(2):337-48.
133. Petronis A, Paterson AD, Kennedy JL. Schizophrenia: an epigenetic puzzle? Schizophr Bull 1999;25:639-55.
134. Heiden A, Willinger U, Scharfetter J, Maszaros K, Kasper S, Aschauer HN. Anticipation in schizophrenia. Schizophr Res 1999;35:25-32.
135. McInnis MG, Mc Mohan FJ, Crow T, Ross CA, De Lisi LE. Anticipation in schizophrenia: a review and reconsideration. Am J Med Genet 1999;88:686-93.
136. Joo EJ, Lee JH, Canon TD, Price RA. Possible association between schizophrenia and a CAG repeat polymorphism in the spinocerebellar ataxia type 1 [SCA 1] gene on human chromosome 6p23. Psychiatr Genet 1999;9:7-11.
137. Valero J, Martorell L, Marine J, Vilella E, Labad A. Anticipation and imprinting in Spanish families with schizophrenia. Acta Psychiatr Scand 1998;97:343-50.
138. Vincent JB, Kalsi G, Klempan T, Tatuch Y, Sherrington RP, Mclnnis MG, et al. No evidence of expansion CAG or GAA repeats in schizophrenia families and monozygotic twins. Hum Genet 1998;103:41-7.
139. Ohara K, Ikeuchi T, Suzuki Y, Ohtani M, Ohara K, Tsuji S. A CAG trinucleotide repeat expansion and familial schizophrenia. Psychiatry Res 2000;94:257-62.
140. Joober R, Benkelfat C, Brisebois K, Toulouse A, Ronald GA, Lal S, et al. Lack of association between the hSkCa3 channel gene CAG polymorphism and schizophrenia. Am J Med Genet 1999;88:154-7.
141. DiMaggio C, Martinez M, Menard JF, Petit M, Thibaut F. Evidence of a cohort effect for age at onset of schizophrenia. Am J Psychiatry 2001;158:489-92.
142. Picco MF, Goodman S, Reed J, Bayless TM. Methodologic pitfalls in the determination of genetic anticipation: the case of Crohn's disease. Ann Intern Med 2001;134:1124-9.
143. Husted J, Scutt LE, Basset AS. Parental transmission and anticipation in schizophrenia. Am J Med Genet 1998;81:156-62.
144. Ohara K, Xu HD, Mori N, Suzuki Y, Xu DS, Wang ZC. Anticipation and imprinting in schizophrenia. Biol Psychiatry 1997; 42:760-6.
145. Imamura A, Honela S, Nakane Y, Okazaki Y. Anticipation in Japanese families with schizophrenia. J Hum Genet 1998;43: 217-23.
146. Asherson P, Walsh C, Williams J, Sargeant M, Taylor C, Clements A, et al. Imprinting and anticipation. Are they relevant to genetic studies of schizophrenia? Br J Psychiatry 1994; 164:619-24.
147. Murray MR, Castle DJ. Aetiology: genetic and environmental risk factors for schizophrenia. In: Gelder GM, Lopez-Ibor JJ, Andreason N, editors. New Oxford Textbook of Psychiatry. 1st ed. Oxford: Oxford University Press; 2000. p. 603.
148. Suraez B, Hampe CL, Van Eedewlgh P. Problems replicating linkage claims in psychiatry. In: Gershon ES, Cloninger CR, editors. New genetic approaches to mental disorders. Washington: American Psychiatric Press; 1995.
149. Nurnberger JI Jr, Foroud T. Genetics of bipolar disorder. Curr Psychiatry Rep 2000;2:147-57.
150. Weiss KM. Genetic variation and human disease: principles and evolutionary approaches. Cambridge: Cambridge University Press; 1993.
151. Risch N, Teng JR. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 1998; 8(12):1273-88.